About Filament BioSolutions
Filament BioSolutions is a Healthcare company based in New York (United States) founded in 2013. Therapeutics and medical foods are developed for various diseases. Its focus areas include Life Sciences, Nutraceuticals Tech and Medical Food. Its competitors include WellGen, Ambra Bio and Square Foods; 3 of its 3 listed competitors have raised funding.
Company details
Developer of therapeutics and medical foods for a wide range of diseases. The companys lead product is FB-2710 FB-2710, an oral, proprietary formulation of an optimal analog of glutamine, treat Oral Mucositis. The company recently announced a partnership with Ajinomoto to develop a portfolio of evidence-based medical foods and an exclusive license agreement with leading academic institutions for the beverage to prevent kidney stones.
- Headquarters New York, United States
- SectorsHealthcare
- Email••••••••
- Website filamentbiosolutions.com
- Investors
Funding Insights of Filament BioSolutions
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Filament BioSolutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2016 | Series C | – | – |
1 investors in total: 1 institutional.
Investors in Filament BioSolutions
Filament BioSolutions has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ajinomoto.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multi-category food and beverage products are manufactured globally. | 1909 | ajinomoto.com | Tokyo, Japan |
Investor details for Filament BioSolutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Filament BioSolutions
2 dated milestones of Filament BioSolutions across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Filament BioSolutions is founded.
- Funding First funding round.
Competitors of Filament BioSolutions
Filament BioSolutions has 3 listed competitors in our database, 3 of them funded. They include WellGen, Ambra Bio and Square Foods.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wellgen.com | 1997 | North Brunswick, United States | $12.5M | Medical foods are developed using nutrigenomics and bioinformatics models. | ||
| ambrabio.com | 2014 | San Diego, United States | $1.82M | Developer of dietary supplements and medical foods | ||
| squarebaby.com | 2013 | Orinda, United States | $1.8M | Customized early-life nutrition meals are delivered biweekly to homes. |
Detailed competitors of Filament BioSolutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Filament BioSolutions (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Filament Biosolutions
Complete news archive for Filament BioSolutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Filament BioSolutions
Filament BioSolutions was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Filament BioSolutions is headquartered in New York, United States. It is registered at New York, New York, United States.
Developer of therapeutics and medical foods for a wide range of diseases. The companys lead product is FB-2710 FB-2710, an oral, proprietary formulation of an optimal analog of glutamine, treat Oral Mucositis. The company recently announced a partnership with Ajinomoto to develop a portfolio of evidence-based medical foods and an exclusive license agreement with leading academic institutions for the beverage to prevent kidney stones.
Filament BioSolutions's top competitors include Ambra Bio, WellGen and Square Foods.
Filament BioSolutions has 1 investor. Key investors include Ajinomoto.